Latest
RampRamp|Highlight AIHighlight AI|NextGen HealthcareNextGen Healthcare|AI, Data & Analytics Network’s Chief AI Officer Exchange Signals a Power Shift in Enterprise AI LeadershipAI, Data & Analytics Network’s Chief AI Officer Exchange Signals a Power Shift in Enterprise AI Leadership|Databricks Launches 2026 Built-On Startup Challenge to Drive Early-Stage AI Infrastructure AdoptionDatabricks Launches 2026 Built-On Startup Challenge to Drive Early-Stage AI Infrastructure Adoption|Surf Therapeutics Receives Jetstream Venture Fund Investment to Advance Ultrasound Neuromodulation for Rheumatoid ArthritisSurf Therapeutics Receives Jetstream Venture Fund Investment to Advance Ultrasound Neuromodulation for Rheumatoid Arthritis|Hill Research Receives Jetstream Venture Fund Investment to Scale AI for Clinical Trial OperationsHill Research Receives Jetstream Venture Fund Investment to Scale AI for Clinical Trial Operations|Tiger Global Invests in PopUp Bagels at $300M Valuation as Brand Expands NationallyTiger Global Invests in PopUp Bagels at $300M Valuation as Brand Expands Nationally|Collide Capital Raises $95M Fund II to Back Early-Stage Startups in Fintech, Supply Chain, and Future of WorkCollide Capital Raises $95M Fund II to Back Early-Stage Startups in Fintech, Supply Chain, and Future of Work|pH7 Technologies Raises $32M Series B to Scale Critical Mineral Extraction From Waste StreamspH7 Technologies Raises $32M Series B to Scale Critical Mineral Extraction From Waste Streams|RampRamp|Highlight AIHighlight AI|NextGen HealthcareNextGen Healthcare|AI, Data & Analytics Network’s Chief AI Officer Exchange Signals a Power Shift in Enterprise AI LeadershipAI, Data & Analytics Network’s Chief AI Officer Exchange Signals a Power Shift in Enterprise AI Leadership|Databricks Launches 2026 Built-On Startup Challenge to Drive Early-Stage AI Infrastructure AdoptionDatabricks Launches 2026 Built-On Startup Challenge to Drive Early-Stage AI Infrastructure Adoption|Surf Therapeutics Receives Jetstream Venture Fund Investment to Advance Ultrasound Neuromodulation for Rheumatoid ArthritisSurf Therapeutics Receives Jetstream Venture Fund Investment to Advance Ultrasound Neuromodulation for Rheumatoid Arthritis|Hill Research Receives Jetstream Venture Fund Investment to Scale AI for Clinical Trial OperationsHill Research Receives Jetstream Venture Fund Investment to Scale AI for Clinical Trial Operations|Tiger Global Invests in PopUp Bagels at $300M Valuation as Brand Expands NationallyTiger Global Invests in PopUp Bagels at $300M Valuation as Brand Expands Nationally|Collide Capital Raises $95M Fund II to Back Early-Stage Startups in Fintech, Supply Chain, and Future of WorkCollide Capital Raises $95M Fund II to Back Early-Stage Startups in Fintech, Supply Chain, and Future of Work|pH7 Technologies Raises $32M Series B to Scale Critical Mineral Extraction From Waste StreamspH7 Technologies Raises $32M Series B to Scale Critical Mineral Extraction From Waste Streams
Back to articles
Jesse Landry

Gyde Acquires Medicare Agency Avid Health to Expand AI-Native Brokerage Platform

Most deals get announced. This one makes a point. Gyde just acquired Avid Health, and while the price tag stays offstage, the intent is loud enough to shake a sleepy category awake. You have Will Johnson and Sam Wiener building an AI-native brokerage out of Austin and New York, pulling from a $60M round led by Lightspeed Venture Partners with Optum Ventures, Crystal Venture Partners, MVP Ventures, and Virtue in the mix. Then you’ve got Gerrick Diaz, who turned Avid Health into the top-rated Medicare agency in Palm Beach by doing the unsexy thing consistently well: showing up for seniors when the system gets confusing and the stakes get personal.

Gyde isn’t rolling up agencies to strip them for parts. They’re buying signal. Avid Health brings a high-touch, education-first model in a Medicare market that eats amateurs for breakfast. Palm Beach is dense, competitive, and brutally honest about who actually delivers. Avid Health didn’t just survive there. They earned trust in a category where trust is usually buried under paperwork and hold music.

Now layer in Gyde’s angle. AI that actually works for brokers, not around them. Systems that handle the grind so advisors can stay human where it counts. The thesis is simple, but not easy: automate the noise, amplify the relationship. If you believe brokers are still the guide through one of life’s most complex decisions, then giving them better tools isn’t optional. It’s oxygen.

Andrew Shults stepping in as CTO adds another gear to that machine. This isn’t theory dressed up as product. This is operator DNA meeting infrastructure that can scale without flattening what made these agencies special in the first place.

And let’s talk timing. Medicare Advantage now covers 35.4M people, over 51% of the eligible population. The market keeps expanding, but complexity is expanding faster. Plans multiply, fine print thickens, and the average consumer is expected to make high-stakes decisions like they’re ordering lunch. That gap between complexity and clarity is where companies either fade out or print relevance.

Gyde is betting that the winners won’t be the loudest platforms or the slickest dashboards. It’ll be the ones that make brokers sharper, faster, and more present when it matters. Avid Health just became the first proof point in that play.

Congratulations to Will Johnson, Sam Wiener, Andrew Shults, and Gerrick Diaz for putting real pieces on the board. This isn’t about adding another logo to a portfolio. It’s about building a system where trust scales without losing its pulse, and where technology finally learns how to sit in the passenger seat instead of grabbing the wheel.